Combining povidone‐iodine with vancomycin can be beneficial in reducing early biofilm formation of methicillin‐resistant Staphylococcus aureus and methicillin‐sensitive S. aureus on titanium surface. Issue 5 (11th January 2023)

• Record Type: Journal Article
• Authors: Taha, Mariam; Arulanandam, Rozanne; Chen, Andrew; Diallo, Jean‐Simon; Abdelbary, Hesham
• Is Part Of: Journal of biomedical materials research. Volume 111:Issue 5(2023)
• Page Start: 1133
• Page End: 1141
• Publication Date: 2023-01-11
• Subjects: antibiotics -- antiseptics -- biofilm -- povidone‐iodine -- S. aureus -- titanium -- vancomycin; Biomedical materials -- Periodicals; 610.28
• DOI: 10.1002/jbm.b.35220
• Languages: English
• ISSNs: 1552-4973

Abstract

Abstract: There is controversial clinical evidence regarding the added antibacterial benefit of locally administering antiseptic solutions or antibiotics to the infected joint space. The objectives of this in vitro study were to test the efficacy of povidone‐iodine (PVP‐I) and vancomycin in treating premature and developed Staphylococcus aureus biofilms grown on titanium implant surfaces. PVP‐I and vancomycin were used to treat immature and developed biofilms formed by two clinical strains of S. aureus (BP043‐MRSA, PB011‐MSSA). S. aureus strains were grown as immature (3 h‐old) or developed (24 h‐old) biofilm. These biofilms were grown on titanium plasma sprayed discs. The treatment regimens tested were: 0.8% PVP‐I, 500 μg/ml vancomycin as well as a combination of vancomycin and PVP‐I. PVP‐I was tested at 3 min, as per current clinical practice, versus 1 min treatment times. In addition, the cytotoxicity of the PVP‐I and vancomycin was tested using fresh skeletal muscle tissue cores harvested from the rat's abdominal muscles using alamarBlue assay. The combination of PVP‐I (3 min) and vancomycin (24 h.) showed synergistic interaction and the best efficacy against immature biofilms formed by both clinical strains. This degree of eradication was statistically significant compared to the untreated control, p < .0001. However, this combination therapy had limited efficiency against developed biofilms. Also, PVP‐I alone was more effective when exposure time was 3 min instead of 1 min against immature biofilm for MRSA, p = .02, and MSSA, p = .01. PVP‐I and vancomycin were not effective against developed biofilm regardless of exposure time. Also, combining PVP‐I and vancomycin was not cytotoxic to muscle tissue. Combining PVP‐I with vancomycin is superior in reducing viable S. aureus cells in immature biofilms grown on titanium surface without causing significant cytotoxicity to muscle tissue. Exposure times and biofilm maturity play a role in dictating the efficacy of using local antiseptics and antibiotics to treat biofilms on implant surfaces.